Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Completion Rate
    0%(0/1)
    Active Trials
    1(50%)
    Terminated
    1(50%)

    Phase Distribution

    Not Applicable
    2
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    N/ANon-phased studies
    2(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Terminated(1)

    Detailed Status

    Terminated1
    Active, not recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    0.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A2 (100.0%)

    Trials by Status

    terminated150%
    active_not_recruiting150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    active_not_recruitingnot_applicable

    Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

    NCT02294435
    terminatednot_applicable

    Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device

    NCT03637374

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT02294435Not Applicable

    Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms

    Active Not Recruiting
    NCT03637374Not Applicable

    Safety, Efficacy, Longitudinal Costs and Patient-Centered Outcomes Using a TAAA Debranching Device

    Terminated

    All 2 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    2